## Clinical Diagnosis The clinical and investigational findings point to a single diagnosis: - Secondary amenorrhea (previously regular or irregular menses) - History of irregular menses since menarche (chronic anovulation) - Normal FSH, LH, and prolactin (rules out hypogonadism and hyperprolactinemia) - Polycystic ovaries on ultrasound (multiple small cysts bilaterally) ## Polycystic Ovary Syndrome (PCOS) **Key Point:** PCOS is the most common endocrine disorder in reproductive-age women and the most frequent cause of secondary amenorrhea due to anovulation. **High-Yield:** PCOS accounts for approximately 70–80% of anovulatory amenorrhea and 20–30% of all secondary amenorrhea cases. ## Diagnostic Criteria for PCOS (Rotterdam 2003) Diagnosis requires 2 of 3 criteria: 1. Oligo- or anovulation (irregular/absent menses) 2. Clinical or biochemical hyperandrogenism 3. Polycystic ovaries on ultrasound (≥12 follicles 2–9 mm in at least one ovary) This patient meets criteria 1 and 3. ## Why PCOS is Most Common | Feature | PCOS | Hypothyroidism | Hyperprolactinemia | Asherman | | --- | --- | --- | --- | --- | | **Prevalence in secondary amenorrhea** | 20–30% | 5–10% | 5–10% | 5–15% | | **FSH/LH status** | Normal or ↑LH:FSH ratio | Normal | Normal | Normal | | **Prolactin** | Normal | Normal | ↑ | Normal | | **Ultrasound findings** | Polycystic ovaries | Normal | Normal | Normal endometrium | | **Menses pattern** | Irregular since menarche | Variable | Variable | Sudden cessation | **Clinical Pearl:** The elevated LH:FSH ratio (often >3:1) in PCOS results from increased GnRH pulse frequency, driving preferential LH secretion and relative FSH suppression. This perpetuates anovulation and hyperandrogenism. **Mnemonic:** **PCOS = Polycystic Ovaries + Chronic Anovulation + (usually) Hyperandrogenism** — the triad that defines the syndrome. ## Management Approach 1. Confirm diagnosis with clinical assessment (hirsutism, acne, male-pattern baldness) and free testosterone or androstenedione if hyperandrogenism suspected 2. Screen for metabolic complications (insulin resistance, dyslipidemia, impaired glucose tolerance) 3. First-line treatment: Combined oral contraceptives or progestin-only therapy for cycle regulation 4. Lifestyle modification (weight loss if overweight) improves ovulation and metabolic parameters
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.